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 ABSTRACT The role of specifi c membrane lipids in transport between endoplasmic reticulum 
(ER) and Golgi compartments is poorly understood. Using cell-free assays that measure stag-
es in ER-to-Golgi transport, we screened a variety of enzyme inhibitors, lipid-modifying en-
zymes, and lipid ligands to investigate requirements in yeast. The  p leckstrin  h omology (PH) 
domain of human Fapp1, which binds phosphatidylinositol-4-phosphate (PI(4)P) specifi cally, 
was a strong and specifi c inhibitor of anterograde transport. Analysis of wild type and mutant 
PH domain proteins in addition to recombinant versions of the Sac1p phosphoinositide-
phosphatase indicated that PI(4)P was required on Golgi membranes for fusion with coat 
protein complex II (COPII) vesicles. PI(4)P inhibition did not prevent vesicle tethering but 
signifi cantly reduced formation of  s oluble  n -ethylmaleimide sensitive factor  a daptor protein 
 re ceptor (SNARE) complexes between vesicle and Golgi SNARE proteins. Moreover, semi-
intact cell membranes containing elevated levels of the ER-Golgi SNARE proteins and Sly1p 
were less sensitive to PI(4)P inhibitors. Finally, in vivo analyses of a  pik1 mutant strain showed 
that inhibition of PI(4)P synthesis blocked anterograde transport from the ER to early Golgi 
compartments. Together, the data presented here indicate that PI(4)P is required for the 
SNARE-dependent fusion stage of COPII vesicles with the Golgi complex. 
 INTRODUCTION 
 The secretory pathway is responsible for delivery of proteins and lip-
ids from their site of synthesis at the endoplasmic reticulum (ER) to 
the cell surface and the many membrane-bound compartments that 
comprise the endomembrane system. Transport between these com-
partments is mediated by membrane vesicles and tubules that bud 
from a donor membrane and selectively target to and fuse with an 
acceptor membrane. This process is vital for cell growth and for main-
tenance of intracellular compartments as distinct biochemical envi-
ronments. Many of the molecular mechanisms that underlie mem-
brane transport are highly conserved between diverse intracellular 
traffi cking events as well as among eukaryotic species (Bonifacino 
and Glick,  2004 ). 
 After synthesis of secretory molecules at the ER, folded cargo pro-
teins are packaged into coat protein complex II (COPII)-derived trans-
port vesicles (Sato and Nakano,  2007 ). In yeast, vesicles then traffi c 
toward the Golgi apparatus and tether to  cis -Golgi membranes in a 
process that depends on Ypt1p, Uso1p, the Grh1/Bug1p complex, 
and the  tra nsport  p rotein  p article (TRAPP)-I complex (Sztul and 
Lupashin,  2006 ;  Behnia  et al. , 2007 ). Vesicle fusion ensues as cognate 
 s oluble  n -ethylmaleimide sensitive factor  a daptor protein  re ceptor 
(SNARE) proteins assemble into  trans -SNARE complexes regulated 
by the function of the SM protein Sly1p (Sudhof and Rothman,  2009 ) 
and the SNARE dissociation chaperones Sec17p (α-SNAP) and 
Sec18p (NSF) (Wickner and Schekman,  2008 ). Current evidence indi-
cates that the vesicle-SNAREs involved in this process are Bet1p and 
Bos1p, whereas Sed5p and Sly1p act on the Golgi compartment 
(Cao and Barlowe,  2000 ). The R-SNARE Sec22p can function in this 
fusion reaction from either vesicles or Golgi membranes (Liu and Bar-
lowe,  2002 ). A complete understanding of the mechanisms underly-
ing ER-to-Golgi transport is limited in part, however, by a lack of 
knowledge of the role of membrane lipids in COPII vesicle budding, 
tethering, and fusion with  cis -Golgi compartments. 
 In addition to well-recognized structural roles in forming mem-
brane bilayers and establishing subcellular compartments within 
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containing [ 35 S]gpαf were generated from microsomes and sepa-
rated from donor ER membranes by centrifugation (Cao and 
Barlowe,  2000 ). In the second stage, washed semi-intact cell mem-
branes pretreated with indicated inhibitors were incubated with [ 35 S]
gpαf containing vesicles in the presence of fusion factors for 1 h at 
23ºC (Cao and Barlowe,  2000 ). As shown in  Figure 1B , U73122, PH, 
and PI-PLC strongly inhibited fusion of COPII vesicles with Golgi ac-
ceptor membranes, whereas C1b and FYVE moderately inhibited 
the reaction. The no acceptor membrane control (no Acpt) refl ects 
the level of Golgi membranes that carry over with COPII vesicles 
from the microsome budding reaction. 
 We next determined whether the inhibitors infl uenced COPII 
vesicle budding or vesicle tethering to Golgi membranes. For this 
assay, washed semi-intact cell membranes containing [ 35 S]gpαf were 
pretreated with indicated inhibitors and then incubated for 30 min 
at 23ºC with COPII proteins to drive vesicle budding ( Cao  et al. , 
1998 ). Because freely diffusible vesicles can be separated from ER 
and Golgi membranes by centrifugation, budding and Uso1p-
dependent tethering of budded vesicles to Golgi membranes can 
be measured by quantifying the level of [ 35 S]gpαf-containing diffus-
ible vesicles in the supernatant fraction ( Cao  et al. , 1998 ). As shown 
in  Figure 1C , U73122 was a strong inhibitor of budding, whereas 
FYVE and PI-PLC were moderate inhibitors of budding. None of the 
inhibitors produced a strong infl uence on vesicle tethering to Golgi 
membranes. We observed, however, that the PH and C1b domains 
caused an increase in diffusible vesicles. We interpret this increase in 
diffusible vesicles to be caused primarily by a block in vesicle fusion 
with Golgi membranes. To ensure that these effects did not arise 
from a loss in membrane integrity, protease protection of luminal 
[ 35 S]gpαf was assessed after inhibitor treatments. As shown in  Figure 
1D , none of the inhibitors compromised the integrity of ER mem-
branes at the concentrations tested, including 80 µM U73122 and 
1 nM PI-PLC (unpublished data). 
 In summary, the tested compounds could be placed into three 
general classes. The fi rst class contains the PI(4,5)P 2 binding do-
mains, ENTH and MED, which did not have a signifi cant effect on 
ER-to-Golgi transport. The second class comprised the inhibitors 
U73122, PI-PLC, and FYVE, which targeted both budding and fu-
sion. At higher concentrations, U73122 and PI-PLC were strong in-
hibitors of budding and fusion, whereas FYVE produced modest 
inhibition of both of these stages. The last class of inhibitors in-
cluded the PH and C1b domains that acted specifi cally at the vesicle 
fusion stage, with the PH domain acting as a more potent inhibitor. 
Further study of the inhibitors U73122, PI-PLC, C1b, and FYVE will 
be necessary to understand their mechanisms of inhibition. We de-
cided to focus on the role of PI(4)P in fusion of COPII vesicles be-
cause PI(4)P is prevalent in the early secretory pathway ( D’Angelo 
 et al. , 2008 ) and because the PH domain acted potently and spe-
cifi cally at the vesicle fusion stage. 
 PI(4)P is required at the Golgi complex for SNARE-mediated 
fusion with COPII vesicles 
 To determine whether the observed inhibition with the PH do-
main was specifi c for PI(4)P, we compared the wild-type PH domain 
(PH WT ) used in  Figure 1 to a mutant (PH N,K ) that does not bind 
PI(4)P ( Dowler  et al. , 2000 ;  Blumental-Perry  et al. , 2006 ). Titration 
of these binding domains in one-stage transport reactions showed 
that PH WT is a dose-dependent transport inhibitor, whereas PH N,K 
did not inhibit transport even at the highest concentrations tested 
( Figure 2A ). Furthermore, in reactions comparing one-stage trans-
port, vesicle budding, and vesicle tethering ( Figure 2B ), treatment 
with 5 µM PH N,K did not have detectable effects on transport, 
eukaryotic cells, specifi c lipid species are known to regulate mem-
brane dynamics (van  Meer  et al. , 2008 ). Among these lipids, diacyl-
glycerol (DAG) and the phosphoinositides (phosphorylated deriva-
tives of phosphatidylinositol [PI]) have been implicated in diverse 
cellular processes, including membrane deformation and vesicle 
traffi cking (Gomez-Fernandez and Corbalan-Garcia,  2007 ; Strahl 
and Thorner,  2007 ;  Mulet  et al. , 2008 ). Few studies, however, have 
addressed the role of specifi c lipid species in transport between ER 
and Golgi compartments. 
 In this study we investigated the lipid requirements for ER-to-
Golgi transport in the budding yeast  Saccharomyces cerevisiae , fo-
cusing on the role of phosphoinositides. In vitro budding, tethering, 
and fusion assays were used to screen phosphoinositide binding 
domains, enzymes that modify phosphoinositides, and inhibitors of 
enzymes involved in phosphoinositide metabolism. We found that 
the  p leckstrin  h omology (PH) domain of human Fapp1, which binds 
specifi cally to PI(4)P (phosphatidylinositol-4-phosphate), was a po-
tent and specifi c inhibitor of ER-to-Golgi transport. Stage-specifi c 
assays demonstrated that PI(4)P was required at the Golgi compart-
ment for fusion of COPII vesicles with Golgi acceptor membranes. 
Moreover, reduction of PI(4)P levels signifi cantly decreased forma-
tion of SNARE complexes between vesicle and Golgi SNARE pro-
teins. Based on the results presented in this study, we propose that 
PI(4)P is an important regulator of COPII vesicle fusion with Golgi 
membranes. 
 RESULTS 
 Characterization of inhibitors of ER-to-Golgi transport 
 To identify specifi c lipid requirements for ER-to-Golgi traffi cking, we 
screened an array of lipid-binding domains, enzymes, and enzyme 
inhibitors in cell-free assays to monitor infl uences on COPII vesicle 
budding, vesicle tethering, or vesicle fusion with Golgi acceptor 
membranes. The following lipid-binding domains were tested: the 
PI(4)P-binding  PH domain of human Fapp1 ( Dowler 
 et al. , 2000 ;  Stahelin  et al. , 2007 ); a tandem repeat of the PI(3)P-
binding  FYVE domainof Eea1 ( Gillooly  et al. , 2000 ); the PI(4,5)P 2 -
binding  ENTH domain of epsin ( Rosenthal  et al. , 1999 ); the PI(4,5)
P 2 -binding marcks-effector domain ( MED ) ( Wang  et al. , 2001 ); and 
the DAG-binding  C1b domain of protein kinase C ( Johnson  et al. , 
2000 ). In addition, we tested a PI-specifi c phospholipase C ( PI-PLC ) 
from  Bacillus cereus ( Ross  et al. , 1992 ) that converts PI into DAG and 
inorganic phosphate; and the PLC inhibitor  U73122 , which prevents 
the conversion of PI(4,5)P 2 into DAG and IP 3 by Plc1p, the only 
known yeast PLC ( Bleasdale  et al. , 1990 ;  Jun  et al. , 2004 ). The con-
centrations of inhibitors used were in the same range as reported to 
inhibit other in vitro traffi cking reactions ( Fratti  et al. , 2004 ;  Jun  et al. , 
2006 ). 
 Inhibitors were initially screened for defects of overall ER-to-Golgi 
transport. In this assay, washed semi-intact cell membranes contain-
ing translocated [ 35 S]glyco-pro-alpha-factor (gpαf) were pretreated 
with indicated inhibitors for 20 min at 4ºC. Reactions were then incu-
bated for 1 h at 23ºC with purifi ed transport factors to drive transport 
of gpαf to the Golgi complex (Barlowe,  1997 ). Upon delivery to the 
Golgi complex, gpαf receives outer-chain α1,6-mannose residues 
that can be immunoprecipitated with anti-1,6-mannose-specifi c se-
rum to quantify gpαf transport ( Baker  et al. , 1988 ). As observed in 
 Figure 1A , U73122 and PH strongly inhibited ER-to-Golgi transport, 
whereas C1b, PI-PLC, and FYVE moderately inhibited the reaction. 
We next determined the specifi c stage(s) of ER-to-Golgi transport 
(budding, tethering, or fusion) that were affected by each inhibitor. 
 To measure COPII vesicle fusion with Golgi membranes, we per-
formed two-stage fusion reactions. In the fi rst stage, COPII vesicles 
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 FIGURE 1:  Screen for inhibitors of ER-to-Golgi transport. (A) Washed semi-intact cells containing [ 35 S]gpαf were 
pretreated with indicated inhibitors for 20 min at 4ºC. Transport reactions were then incubated with Recon proteins 
(COPII, Uso1p, and LMA1) and an ATP regeneration system at 23ºC for 1 h. The amount of Golgi-modifi ed [ 35 S]gpαf was 
measured to determine transport effi ciency. NA is the background level of transport in the absence of transport factors. 
(B) Semi-intact cell acceptor membranes were pretreated with indicated inhibitors for 20 min at 4ºC and then incubated 
with COPII vesicles containing [ 35 S]gpαf in the presence of fusion factors (U/L: Uso1p and LMA1) and an ATP 
regeneration system at 23ºC for 1 h. Golgi-modifi ed [ 35 S]gpαf was measured to determine fusion effi ciency. The no Acpt 
condition represents the background level of fusion in the absence of semi-intact cell acceptor membranes. 
(C) Pretreated, semi-intact cells as in panel A were incubated with COPII or COPII plus Uso1p for 30 min at 23ºC. To 
measure budding (black bars) or tethering (white bars), diffusible vesicles containing [ 35 S]gpαf were separated from 
semi-intact cell membranes by centrifugation. (D) Mock-budding reactions as in panel C were treated with trypsin, and 
total protease protected [ 35 S]gpαf was quantifi ed to assess membrane integrity. 
whereas 5 µM PH WT inhibited transport and caused an apparent 
increase in diffusible vesicles (also observed in  Figure 1C ). 
Because tethering was largely unaffected ( Figure 2B ), we con-
clude that this effect was caused primarily by inhibition of vesicle 
fusion. 
 Tethered vesicles could be prevented from fusing with Golgi 
membranes if formation of  trans -SNARE complexes was blocked or 
if assembled  trans -SNARE complexes could not catalyze membrane 
fusion. To determine whether PH WT treatment prevents formation of 
 trans- SNARE complexes, we used an assay that measures the 
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that produce cross-linked adducts when assembled into SNARE 
complexes (Flanagan and Barlowe,  2006 ). Briefl y, we performed 
two-stage fusion reactions chasing Bet1p I83C vesicles into Sec22p D153C 
acceptor membranes and monitored formation of the Bet1p-Sec22p 
disulfi de cross-linked heterodimer in parallel with transport of [ 35 S]
gpαf. As shown in  Figure 2C , the inhibition of gpαf transport by 
5 µM PH WT mirrors the inhibition of SNARE complex formation, 
whereas 5 µM PH N,K did not cause detectable inhibition in this assay. 
Taken together, these data indicate that the PH WT domain inhibits 
fusion of COPII vesicles through specifi c interactions with PI(4)P and 
suggests that the role of PI(4)P in fusion is upstream or simultaneous 
with  trans- SNARE complex assembly. 
 To further explore these results, we sought to biochemically de-
plete PI(4)P by treating membranes with recombinant Sac1, a phos-
phoinositide lipid phosphatase that removes the phosphate residue 
from the inositol head group of PI(4)P. As a control we used the 
catalytically inactive mutant Sac1 C392S ( Maehama  et al. , 2000 ). Sur-
prisingly, titration of these proteins in two-stage fusion reactions 
showed that the mutant Sac1 C392S was a potent inhibitor of fusion 
whereas the Sac1 WT protein did not display an equal inhibitory effect 
( Figure 3A ). Moreover, in transport, budding, tethering, and two-
stage fusion assays, addition of 2.8 µM Sac1 C392S inhibited transport, 
caused COPII vesicles to accumulate, inhibited vesicle fusion, and 
blocked formation of cross-linked SNARE complexes ( Figure 3, B 
and  C ). These results are similar to PH WT domain inhibition and sug-
gested that the catalytically inactive mutant Sac1 C392S acts as a PI(4)
P lipid ligand. To test this hypothesis, we performed liposome-bind-
ing assays to monitor binding of Sac1 WT and Sac1 C392S to PI(4)P lipo-
somes. As shown in  Figure 3D , 32% of Sac1 C392S bound to PI(4)P li-
posomes (lane 12) compared to 2% background binding to PI 
liposomes (lane 10). In contrast, 13% of Sac1 WT bound to PI(4)P lipo-
somes (compare lanes 12 and 6) with similar background binding to 
PI liposomes (compare lanes 10 and 4). Together, these results indi-
cate that the catalytically inactive Sac1 C392S mutant inhibits vesicle 
fusion through tight binding to membrane PI(4)P as observed for the 
PH WT domain. 
 We were surprised that Sac1 WT treatment in the 5 µM range 
did not produce stronger inhibition of vesicle fusion. We consid-
ered, however, the possibility that our assay conditions may not 
be optimal for Sac1 phosphatase activity to deplete PI(4)P from 
semi-intact cell membranes. To promote Sac1 WT activity, semi-
intact cell acceptor membranes were incubated with higher con-
centrations of Sac1 WT for 30 min at 12ºC and then were diluted 
into standard two-stage fusion reactions. As shown in  Figure 4A , 
pretreatment of acceptor membranes with increasing concentra-
tions of Sac1 WT caused a dose-dependent inhibition of vesicle fu-
sion with concentrations greater than 25 µM near the minus ac-
ceptor control level. It should be noted that after pretreatment of 
membranes with the indicated concentration of Sac1 WT , mem-
branes were diluted approximately eightfold such that maximal 
fi nal concentrations of Sac1 WT in transport reactions were near 
those used in  Figure 3A . Therefore the inhibitory effects of Sac1 WT 
were likely due to catalytic activity of the enzyme and not due to 
lipid ligand binding. Finally, pretreatment of acceptor membranes 
with 50 µM Sac1 WT also caused an accumulation of diffusible ves-
icles in budding reactions and strong inhibition of SNARE com-
plex formation ( Figure 4, B and  C ). These fi ndings suggest that 
PI(4)P present on acceptor membranes is required for effi cient 
SNARE complex assembly and fusion of ER-derived vesicles with 
Golgi membranes. 
 To further support the proposal that Sac1 WT inhibition was due to 
the catalytic phosphatase activity of the enzyme and not due to 
steric hindrance of binding to PI(4)P, Sac1 WT -treated membranes 
formation of disulfi de cross-links between cognate SNARE protein 
pairs. In this assay, the SNARE proteins Bet1p and Sec22p contain 
cysteine residues introduced into their SNARE domains in positions 
 FIGURE 2:  PH WT inhibits COPII vesicle fusion with Golgi membranes. 
(A) Titration of PH WT (black squares) and PH N,K (white squares) in 
one-stage transport experiments was performed as described in 
 Figure 1A . Maximum transport was equivalent to 20% overall 
ER-to-Golgi transport. NA represents background level of transport in 
the absence of transport factors. (B) Overall transport (black bars), 
budding (gray bars) and tethering (white bars) assays were carried out 
simultaneously as in  Figure 1 . PH WT and PH N,K were tested at 5 µM. 
Arrows show background transport in the absence of transport 
factors. (C) Fusion reactions were conducted as in  Figure 1B and 
monitored for the formation of cross-linked Bet1p I83C -Sec22p D153C 
heterodimers (white bars and immunoblot) and for Golgi modifi cation 
of [ 35 S]gpαf (black bars). Reactions were probed with antibodies 
against Sec22p and Och1p (loading control). Arrow indicates position 
of cross-linked linked Bet1p I83C -Sec22p D153C heterodimer. 
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contained 78 pmol PI(4)P/10 9 cells (Supplemental Figure S1B). Fi-
nally, we found that N-ethylmaleimide inactivation of Sac1 WT 
( Maehama  et al. , 2000 ) completely prevented its inhibitory activity in 
two-stage fusion reactions compared to mock treated Sac1 WT (Sup-
plemental Figure S1C). Based on the collective evidence, we con-
clude that pretreatment of membranes with 50 µM Sac1 WT inhibits 
vesicle fusion through reduction of membrane PI(4)P levels. 
 The fact that preincubation of acceptor membranes with Sac1 WT 
inhibited transport ( Figure 4 ) suggested that PI(4)P is required on 
Golgi membranes. PI(4)P, however, may also be required on COPII 
vesicles for fusion with the Golgi compartment. To address this is-
sue, we took advantage of the fact that budding is not inhibited by 
treatment with 50 µM Sac1 WT ( Figure 4B ). For this experiment, mi-
crosomes containing [ 35 S]gpαf were treated with 50 µM Sac1 WT or 
buffer for 30 min at 12ºC. Treated microsomes were then used to 
were washed prior to two-stage fusion reactions to remove excess 
Sac1 WT . As shown in  Figure 4D , this wash did not substantially re-
duce transport in mock treated membranes (washed vs. unwashed), 
whereas the 50 µM Sac1 WT pretreatment inhibited transport to near 
the minus acceptor control level and was not rescued by the wash. 
To show that the wash procedure was effective, immunoblot analysis 
documented that ∼76% of Sac1 WT was removed after washing 
treated semi-intact cell acceptor membranes ( Figure 4D ). Moreover, 
we observed that formation of the Bet1p I83C -Sec22p D153C cross-
linked heterodimer was strongly inhibited by Sac1 WT pretreatment 
and was not rescued by the wash (Supplemental Figure S1A). In ad-
dition, direct measurement of PI(4)P levels in semi-intact cell mem-
branes demonstrated that the Sac1 WT pretreatment was effective. 
After control incubations, semi-intact cell membranes contained 
123 pmol PI(4)P/10 9 cells, whereas Sac1 WT -treated membranes 
 FIGURE 3:  Sac1 C392S inhibits COPII vesicle fusion with Golgi membranes. (A) Titration of Sac1 WT (black squares) and 
Sac1 C392S (white squares) in two-stage fusion reactions was performed as in  Figure 1B . Maximum transport was equivalent 
to 32% fusion. NA shows the background level of fusion in the absence of transport factors and –Acceptor represents 
fusion level in the absence of added semi-intact cell acceptor membranes. (B) Overall transport (black bars), budding 
(gray bars), and tethering (white bars) assays were carried out simultaneously as in  Figure 2B . Sac1 WT and Sac1 C392S were 
tested at 2.8 µM. Arrows show background transport in the absence of transport factors. (C) Fusion reactions were 
carried out as in  Figure 2C and monitored for the formation of cross-linked Bet1p I83C -Sec22p D153C heterodimers (white 
bars and immunoblot) and for Golgi-modifi ed [ 35 S]gpαf (black bars). (D) Sac1 C392S is a PI(4)P lipid ligand. Sac1 WT or 
Sac1 C392S (3 µM) were incubated with buffer (lanes 1, 2, 7, and 8), PI liposomes (lanes 3, 4, 9, and 10), or PI(4)P liposomes 
(lanes 5, 6, 11, and 12) for 30 min at 30ºC. Liposomes were recovered by sedimentation, and the amount of protein in the 
supernatant (S) or co-sedimenting with liposomes in the pellet (P) was determined by Coomassie blue staining of 7.5% 
SDS–PAGE gels. Liposome molar composition: 50% PC, 30% PE, 10% PS, and 10% PI or PI(4)P. 
Volume 22 January 15, 2011 COPII vesicle fusion requires PI(4)P | 221 
We performed two-stage fusion reactions with increasing concen-
trations of cytosol in the presence of 3, 5, or 7 µM PH WT . High con-
centrations of cytosol, however, did not rescue PH WT inhibition of 
COPII vesicle fusion with Golgi membranes (Supplemental Figure 
S2) suggesting that such a PI(4)P binding fusion factor was not pres-
ent in our cytosol preparation. 
 Next, we treated semi-intact cells with inhibitory concentrations 
of PH WT , Sac1 WT , or Sac1 C392S and examined if known proteins in-
volved in vesicle tethering and fusion were displaced from the 
membranes. We did not detect differences in membrane associa-
tion of Ypt1p, Uso1p, Sly1p, or subunits of the  c onserved  o ligo-
meric Golgi (COG) and TRAPP complexes. In contrast, low levels of 
the SNARE disassembly chaperone Sec18p and the Grh1/Bug1 
tethering complex were detected in the supernatant fraction after 
treatment of semi-intact cell membranes (Supplemental Figure S3). 
This observation suggested that PI(4)P levels infl uence membrane 
generate COPII vesicles, and vesicles were purifi ed by fl otation on 
Nycodenz density gradients (Barlowe,  1997 ). In two-stage fusion re-
actions, fl oated vesicles containing [ 35 S]gpαf were chased into un-
treated acceptor membranes. Notably, vesicles generated in the 
presence of 50 µM Sac1 WT chased into acceptor Golgi membranes 
as effi ciently as control vesicles ( Figure 5 ), indicating that PI(4)P is 
required only at the Golgi compartment for fusion with COPII vesi-
cles. Together these fi ndings demonstrate that PI(4)P is required on 
Golgi acceptor membranes for  trans- SNARE complex assembly and 
subsequent fusion with COPII vesicles. 
 ER-Golgi fusion factors in PI(4)P-dependent vesicle fusion 
 We hypothesized that PI(4)P on Golgi membranes interacted with 
protein fusion factors to mediate bilayer fusion. If PI(4)P recruits a 
cytosolic factor for COPII vesicle fusion with Golgi membranes, ad-
dition of crude cytosol might be expected to reverse PH WT inhibition. 
 FIGURE 4:  Pretreatment of membranes with 50 µM Sac1 WT inhibits COPII vesicle fusion with Golgi membranes. (A) 
Semi-intact cell membranes pretreated with Sac1 WT at 12ºC for 30 min were used in two-stage fusion reactions as 
described in  Figure 1B . Maximum transport is equivalent to 35% fusion. (B) Semi-intact cells pretreated with 50 µM 
Sac1 WT as in panel A were used in budding (black bars) and tethering (gray bars) assays as in  Figure 1C . NA (white bars) 
shows background budding in the absence of transport factors. (C) Sec22p D153C semi-intact cells were pretreated with 
50 µM Sac1 WT as in panel A, and then fusion reactions were carried out as in  Figure 2C monitoring the formation of 
cross-linked Bet1p I83C -Sec22p D153C heterodimers (white bars and immunoblot) and Golgi-modifi ed [ 35 S]gpαf fusion (black 
bars). (D) Reactions were assembled as in panel A and washed twice with excess buffer prior to setting up two-stage 
fusion reactions. NA shows background fusion in the absence of fusion factors, and the arrow indicates background 
fusion in the absence of acceptor membranes. Aliquots of the treated membranes were immunoblotted for Sac1p using 
an anti-penta-His antibody and for the Golgi membrane protein Och1p (loading control). Arrow indicates Och1p; 
asterisk indicates a cross-reactivity of anti-Och1p with the Sac1 WT protein. 
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PI(4)P in fusion might be required downstream of tethering but be-
fore or simultaneous with SNARE protein function. Thus, we rea-
soned that overexpression of the fusion machinery (all four ER-Golgi 
anterograde SNAREs and Sly1p) might yield acceptor membranes 
that are resistant or less sensitive to the PH WT inhibitor. We con-
structed the overproducer strains by transforming wild-type yeast 
with empty vectors (control) or with 2µ  plasmids containing the 
 BET1 ,  BOS1 ,  SEC22 ,  SED5 , and/or  SLY1 under control of their en-
dogenous promoters. Different combinations of SNARE overex-
pressing acceptor membranes were tested in two-stage fusion reac-
tions. Overexpression of certain combinations produced modest 
levels of resistance to 3 or 5 µM PH WT (unpublished data). Overex-
pression of all four anterograde ER-Golgi SNAREs and  SLY1 , how-
ever, provided a higher level of resistance to PH WT compared to the 
partial overexpressor strains. Therefore we further characterized this 
overexpressor strain. 
 To determine fold overexpression and test whether overexpres-
sion infl uenced other ER-to-Golgi transport factors, we prepared 
semi-intact cell membranes from the strain overexpressing  BET1 , 
 BOS1 ,  SEC22 ,  SED5 , and  SLY1 (from here on referred to as the over-
expressor) for comparison with control strains. Experiments to as-
sess the distribution of proteins contained in total, soluble, and 
membrane pellet fractions monitored the overexpressed proteins 
and a variety of other ER- and Golgi-localized markers ( Figure 6A ). 
We observed that Bet1p, Bos1p, Sec22p, Sed5p, and Sly1p were 
overexpressed three- to ninefold (compare total lanes), whereas the 
expression level and fractionation behavior of other marker proteins 
was not detectably altered. 
 Bet1p, Bos1p, Sec22p, and Sed5p are known to cycle between 
the ER and Golgi compartments and are effi ciently packaged into 
COPII vesicles (Cao and Barlowe,  2000 ); therefore, we expected in-
creased levels of these SNARE proteins in COPII vesicles from 
association of specifi c fusion factors. We note, however, that addi-
tion of a crude cytosol, which contained Grh1p, Bug1p, and Sec18 
(Supplemental Figure S2), or the addition of purifi ed Sec18p 
( see Figure 7 later in the paper ) did not compete with PH WT for 
inhibition of transport. 
 To further explore the hypothesis that a PI(4)P binding factor pro-
motes COPII vesicle fusion, we took a candidate-based approach to 
screen viable yeast deletion strains lacking proteins shown to have 
affi nity for PI(4)P (Supplemental Table S1). Previous reports have 
characterized PI(4)P binding proteins in yeast based on an analysis 
of PH domain–containing proteins ( Yu  et al. , 2004 ) and on lipid-
binding assays using proteome chips ( Zhu  et al. , 2001 ). We pre-
pared semi-intact cell acceptor membranes from more than 20 dif-
ferent candidate strains, including the combined  osh1Δ osh2Δ 
osh3Δ deletion mutant ( Beh  et al. , 2001 ) to account for potential 
redundancy. In two-stage fusion reactions, all of the acceptor mem-
branes tested displayed wild-type levels of fusion with the excep-
tion of  gcs1Δ strain, which was reduced to 47% of the wild-type level 
(Supplemental Table S1).  GCS1 encodes an Arf-GAP known to act in 
COPI-dependent Golgi to ER retrograde transport but is also re-
ported to regulate assembly of ER-Golgi SNARE protein complexes 
( Poon  et al. , 1999 ; Schindler and Spang,  2007 ). Further experimen-
tation will be required to determine whether the  gcs1Δ mutation 
produces a direct or indirect effect on fusion of COPII vesicles with 
Golgi membranes. We note, however, that addition of crude cytosol 
to transport reactions, which contained Gcs1p, did not reverse PH WT 
inhibition of transport (Supplemental Figure S2). 
 We also considered the possibility that essential membrane-
bound proteins could be involved in PI(4)P-dependent vesicle fusion 
at Golgi membranes. The ER-Golgi SNARE proteins could interact 
with PI(4)P as suggested by studies of other SNARE-dependent mem-
brane fusion events ( James  et al. , 2008 ;  Lam  et al. , 2008 ; Mendonsa 
and Engebrecht,  2009 ; Mima and Wickner,  2009 ; Murray and Tamm, 
 2009 ). To investigate this hypothesis we characterized PI(4)P-depen-
dent vesicle fusion in membranes overexpressing Sly1p and the four 
ER-Golgi SNARE proteins. 
 Overexpression of SNARE proteins and Sly1p alleviates the 
PI(4)P requirement in fusion 
 Because inhibition of PI(4)P function in ER-to-Golgi transport pre-
vented formation of SNARE complexes but did not have a signifi -
cant effect on vesicle tethering, we hypothesized that the role of 
 FIGURE 5:  PI(4)P is required at the Golgi for fusion with COPII 
vesicles. Microsomes containing [ 35 S]gpαf were treated with 50 µM 
Sac1 WT or buffer (mock) at 12ºC for 30 min. Treated microsomes were 
then used to generate COPII vesicles, and vesicles were purifi ed by 
fl otation on Nycodenz density gradients. Isolated vesicles were then 
incubated in two-stage fusion reactions with untreated semi-intact cell 
acceptor membranes as in  Figure 1B . 
 FIGURE 6:  Characterization of membranes that overexpress 
anterograde ER-Golgi SNARE proteins and Sly1p. (A) Semi-intact cells 
from the overexpressor strain containing 2µ- BET1 , 2µ- BOS1 , 
2µ- SEC22 , 2µ- SED5 , and 2µ- SLY1 (CBY3061) and the wild-type strain 
(CBY3062) were fractionated into soluble (S100) and pellet (P100) 
fractions for immunoblot analysis. (B) Budding reactions in which 
CBY3061 and CBY3062 microsomes were incubated in the absence (–) 
or presence (+) of COPII proteins for 30 min at 23ºC. Immunoblots 
compare indicated proteins in budded vesicle fractions with one-tenth 
of total (T) budding reactions. Longer exposures (dark) are included 
for the Sec22p and Bet1p immunoblots. 
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indicate that increasing the amount of anterograde ER-Golgi SNARE 
proteins and Sly1p does not bypass but alleviates the requirement 
for PI(4)P on Golgi membranes for vesicle fusion. 
overexpressor membranes. Relative COPII packaging effi ciencies 
were measured in budding assays using microsomes from the wild 
type and overexpressor strains. As shown in  Figure 6B , the ER-Golgi 
SNARE proteins were 8- to 15-fold more abundant in overexpressor 
microsomes compared to wild type (total lanes). In budding assays, 
we observed increased levels of Bet1p (1.5-fold), Bos1p (2-fold), and 
Sec22p (5-fold) in COPII vesicles. Sed5p and Sly1p, however, were 
not increased in vesicles, which may be explained by the steady-
state localization of Sed5p to  cis -Golgi membranes (Wooding and 
Pelham,  1998 ). As a negative control, the ER resident Sec63p was 
not packaged into COPII vesicles. The packaging of known COPII 
vesicle proteins, such as Erv25p and Erv46p, was not changed. 
Taken together, these data show that COPII vesicles from overex-
pressor membranes contain more Bet1p, Bos1p, and Sec22p than 
wild-type membranes and that the distribution of other proteins in-
volved in ER-to-Golgi transport was not sensitive to overexpression 
of Sly1p and the anterograde ER-Golgi SNARE proteins. 
 We next investigated how this overexpression condition infl u-
enced vesicle fusion. Addition of Sec18p to one-stage and two-
stage fusion reactions has a minor effect on fusion rates, probably 
because of the abundant levels of Sec18p found in association with 
semi-intact cell membranes (Barlowe,  1997 ). We reasoned, however, 
that overexpressor membranes might require additional Sec18p to 
prime SNARE proteins for maximal fusion. Titration of recombinant 
Sec18p in one-stage transport reactions using overexpressor mem-
branes indicated that ∼4 µM produced maximal stimulation (unpub-
lished data), similar to previous titrations of Sec18p using washed 
Golgi membrane preparations (Barlowe,  1997 ). As shown in 
 Figure 7A , we observed that transport with overexpressor and con-
trol membranes was indistinguishable in the absence of Sec18p. 
Addition of 4 µM Sec18p, however, stimulated transport ∼1.6-fold in 
overexpressor membranes, whereas wild-type membranes were not 
stimulated by Sec18p addition. Moreover, there was a decrease in 
sensitivity to inhibition by 3 µM PH WT in the overexpressor mem-
branes compared to control, which was further enhanced by addi-
tion of 4 µM Sec18p. Interestingly, the level of transport in the over-
expressor membranes in the presence of Sec18p and PH WT was 
similar to that of wild-type membranes in the absence of PH WT 
( Figure 7A ). 
 Sec18p likely stimulates transport at the vesicle fusion stage by 
resolving abundant  cis -SNARE complexes in overexpressor mem-
branes, although there could be an infl uence on vesicle budding. To 
test this possibility, we performed [ 35 S]gpαf budding reactions from 
wild type and overexpressor microsomes and found that there were 
no signifi cant differences in gpαf budding between the wild type 
and overexpressor membranes with or without added Sec18p 
( Figure 7B ). These data indicate that Sec18p treatment potentiates 
fusion of COPII vesicles and that transport in the presence of 4 µM 
Sec18p with the overexpressor membranes is signifi cantly less sen-
sitive to the PH WT inhibitor. 
 Finally, acceptor membranes from the overexpressor strain were 
used in two-stage fusion experiments using wild-type vesicles in the 
presence or absence of recombinant Sec18p and increasing con-
centrations of PH WT . We observed that PH WT produced the expected 
dose-dependent inhibition of transport when chasing wild-type 
vesicles into wild-type membranes ( Figure 7C , compare to  Figure 
2A ) and that addition of Sec18p to this reaction displayed partial 
rescue of the PH WT inhibition. Interestingly, transport was signifi -
cantly less sensitive to increasing concentrations of PH WT inhibitor 
when wild-type vesicles were chased into overexpressor mem-
branes, and the addition of Sec18p signifi cantly enhanced this res-
cue ( Figure 7C and Supplemental Figure S4). Together, these data 
 FIGURE 7:  Overexpression of anterograde ER-Golgi SNAREs and 
Sly1p partially rescues PH WT inhibition. (A) Transport in wild-type 
(CBY3062) and overexpressor (CBY3061) semi-intact cells incubated 
for 20 min at 4ºC with 3 µM PH WT and/or 4 µM Sec18p followed by 
transport for 1 h at 23ºC. (B) Microsomes treated as in panel A were 
mock treated (NA) or incubated with COPII proteins for 30 min at 
23ºC to monitor budding. (C) Indicated semi-intact cell acceptor 
membranes were pretreated with PH WT and/or 4 µM Sec18p for 
20 min at 4ºC, then were incubated with COPII vesicles containing 
[ 35 S]gpαf in the presence of fusion factors for 1 h at 23ºC. The –Acpt 
condition indicates background fusion in the absence of added 
acceptor membranes. The data in panel C are plotted relative to 
control transport levels in Supplemental Figure S4. 
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 trans- compartments, could cause inhibition of  trans- Golgi export 
fi rst, followed by inhibition of ER-to-Golgi transport. To test this 
hypothesis, we modifi ed the protocol from Audhya and colleagues 
to increase the amount of time mutant cells were incubated at the 
restrictive temperature prior to initiating the pulse-chase experiment 
( Audhya  et al. , 2000 ). As shown in  Figure 8A ,  pik1–83 cells displayed 
a dramatic block in maturation of the ER-form (p1) of carboxypepti-
dase Y (CPY) into the Golgi-form (p2) compared to wild-type cells, 
indicative of a block in ER-to-Golgi transport. Taken together, these 
results suggest that traffi c out of the  trans- Golgi complex is more 
sensitive to PI(4)P depletion ( Audhya  et al. , 2000 ) but that continued 
defi ciency in Pik1p activity blocks transport to the  cis -Golgi com-
partment. In addition, it is also possible that PI(4)P could be re-
quired for additional transport steps within the Golgi complex. 
 Given the highly dynamic nature of the Golgi complex, we inves-
tigated an alternative possibility that loss of Pik1p caused a general 
disassembly of Golgi structures. To address this possibility, we com-
pared growth rates and Golgi morphologies in  pik1–83 and wild-
type cells after shift to the restrictive temperature. As shown in 
 Figure 8B , both strains displayed similar growth kinetics and re-
mained metabolically active up to 1 h after the shift to 37°C. At the 
 PI(4)P is required for ER-to-Golgi transport in vivo 
 A central role for PI(4)P in Golgi secretory function was fi rst reported 
in  sec14 and  pik1 mutants, which show reduced levels of cellular 
PI(4)P and kinetic defects in Golgi transport at restrictive tempera-
tures ( Hama  et al. , 1999 ; Walch-Solimena and Novick,  1999 ;  Audhya 
 et al. , 2000 ). At steady state, Pik1p localizes to  trans- Golgi and in-
ner-nuclear compartments (Walch-Solimena and Novick,  1999 ; 
 Strahl  et al. , 2005 ). In both yeast and mammalian cells, Pik1p-gener-
ated Golgi PI(4)P is required to recruit clathrin adaptor proteins for 
export from  trans- Golgi membranes ( D’Angelo  et al. , 2008 ;  Clague 
 et al. , 2009 ). Therefore a reduction in PI(4)P at Golgi membranes 
caused by shifting  pik1 mutants to the restrictive temperature 
strongly inhibits anterograde transport from the Golgi compart-
ment. It should be noted, however, that ER-to-Golgi transport in 
these experiments was also kinetically delayed (Walch-Solimena 
and Novick,  1999 ;  Audhya  et al. , 2000 ). 
 On the basis of these reports and our in vitro data, we hypoth-
esized that a pool of Golgi-localized PI(4)P is required for proper 
traffi cking into  cis -Golgi compartments as well as out of the  trans-
 Golgi complex. We also considered the possibility that a PI(4)P 
gradient across the Golgi complex, with highest requirements at 
 FIGURE 8:  Depletion of PI(4)P in vivo causes a block in ER-to-Golgi transport and infl uences Golgi morphology. (A) 
Wild-type (SEY6210) and  pik1–83 (AAY104) strains grown to a mid-log stage at 26ºC were shifted to 37ºC for 45 min, 
pulsed for 7 min at 37ºC, and chased at 37ºC for the indicated times. The ER (p1), Golgi (p2), and vacuolar (m; mature) 
forms of CPY are indicated. Note the block in maturation of p1 CPY in the mutant. (B–E) Wild-type (CBY2970, CBY2973, 
CBY2974) and  pik1–83 (CBY2980, CBY2983, and CBY2984) cells expressing Sec63p-GFP (C), Sec21p-GFP (D), or 
Sec7p-GFP (E) were grown on YPD at 26ºC to 0.4 OD 600 /ml and shifted to 37ºC. (B) Cultures were analyzed for growth 
over time by absorbance. (C-E)  pik1–83 cells retain ER (C),  cis -Golgi (D), and late-Golgi (E) structures. Scale bars: 5 µm. A 
quantitative analysis of ER and Golgi morphologies observed in a population of cells at the 1-h time point is provided in 
Supplemental Figure S5. 
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 et al. , 2009 ). Golgi levels of PI(4)P are thought to be regulated by 
multiple activities, including the PI-transfer protein Sec14p ( Mousley 
 et al. , 2007 ), the  trans- Golgi localized PI 4-kinase Pik1p, and the 
ER-localized phosphoinositide-phosphatase Sac1p (Mayinger, 
 2009 ). Using a PI(4)P-specifi c PH domain lipid ligand and a recombi-
nant Sac1p-phosphatase to reduce the levels of PI(4)P in vitro, we 
observed that PI(4)P was not involved in budding or tethering of 
COPII vesicles, but was required on Golgi acceptor membranes for 
fusion with COPII vesicles. More specifi cally, we found that inhibi-
tion of PI(4)P function reduced formation of the SNARE complexes 
that catalyze fusion of vesicles with Golgi membranes. 
 In vitro COPII vesicle budding from synthetic liposomes was 
shown to require low concentrations of PI(4)P and PI(4,5)P 2 to 
achieve effi cient binding of Sec23/Sec24 and to support vesicle 
budding ( Matsuoka  et al. , 1998 ). Our data indicate that neither 
phosphoinositide is required for COPII vesicle budding on ER 
membranes, although other acidic phospholipids on the ER sur-
face could satisfy this requirement. Alternatively, recruitment of 
Sec23/Sec24 by protein cargo molecules on the surface of ER 
membranes may be suffi cient to assemble COPII coats for vesicle 
budding, as observed on synthetic proteoliposomes (Sato and 
Nakano,  2005 ). 
 In mammalian cells, evidence suggests that PI(4)P is required 
for remodeling ER exit sites and regulating COPII vesicle budding 
( Blumental-Perry  et al. , 2006 ). In vitro, we did not detect a require-
ment for PI(4)P in COPII budding from yeast ER, and in vivo  pik1–83 
yeast cells shifted to a restrictive temperature did not accumulate 
ER membranes or cause disassembly of Golgi compartments as 
would be expected if COPII budding were inhibited (Wooding and 
Pelham,  1998 ;  Prinz  et al. , 2000 ;  Heidtman  et al. , 2003 ;  Kamena 
 et al. , 2008 ;  Lorente-Rodriguez  et al. , 2009 ). This contrast may be 
explained by differences in the structural organization of ER export 
sites between yeast and mammalian cells. We speculate, however, 
that PI(4)P functions in both yeast and mammalian cells for fusion 
of COPII vesicles with Golgi membranes based on the evidence 
that, in both species, Golgi PI(4)P is required for Golgi secretory 
function ( D’Angelo  et al. , 2008 ) and that Golgi PI(4)P levels are 
tightly regulated by PI 4-kinases and PI(4)P 4-phosphatases in re-
sponse to growth conditions (Mayinger,  2009 ). In addition, PI(4)P 
was recently observed to signifi cantly colocalize with  cis -Golgi 
tethering factors in mammalian cells ( Hammond  et al. , 2009 ). 
Further experimentation will be needed, however, to demonstrate 
whether PI(4)P mediates fusion at early Golgi compartments in 
mammalian cells. 
 On the basis of the collective fi ndings, we hypothesize that a 
traffi cking-dependent gradient of PI(4)P is established across the 
Golgi complex with its highest levels at the  trans- Golgi and lowest 
levels at the  cis -Golgi compartments. This PI(4)P gradient would be 
necessary for transport into and out of the Golgi complex. Because 
Pik1p and Sac1p have been implicated in regulating Golgi PI(4)P 
levels in yeast and mammalian cells (Mayinger,  2009 ), we propose 
that this gradient is regulated by Pik1p and Sac1p activities. This 
hypothesis is supported by our observation that  pik1–83 cells 
shifted to a restrictive temperature for 1 h displayed morphological 
defects in  trans- Golgi structures, accompanied by moderate de-
fects in  cis -Golgi structures. In this framework, inactivation of Pik1p 
would initially inhibit anterograde transport from  trans- Golgi mem-
branes (Walch-Solimena and Novick,  1999 ;  Audhya  et al. , 2000 ). As 
retrograde transport continues, depletion of PI(4)P from  cis -Golgi 
compartments would ultimately inhibit fusion of ER-derived vesi-
cles with Golgi membranes. This proposal is consistent with our 
analysis of  pik1–83 semi-intact cell membranes in vitro, which did 
2- and 3-h time points, however, the  pik1–83 cells ceased growth. 
We note that our chase was initiated at a time point that roughly 
corresponded to the last chase time point of the published data 
( Audhya  et al. , 2000 ) and that the 5- and 15-min time points in our 
pulse-chase experiment corresponded to a total time at the restric-
tive temperature of 57 and 67 min, respectively, suggesting that the 
observed block in ER-to-Golgi transport was not caused by a gen-
eral metabolic defect. 
 To inspect organelle morphologies after the temperature shift, 
we monitored ER,  cis -Golgi, and  trans- Golgi markers by fl uores-
cence microscopy of Sec63p-GFP, Sec21p-GFP, and Sec7p-GFP, 
respectively. As shown in  Figure 8, C – E , ER and Golgi structures 
were visible in mutant cells after 1 h and even 2 h at the restrictive 
temperature. Based on the time frame of our pulse-chase experi-
ment, we quantifi ed morphologies 1 h after shift to the restrictive 
temperature. ER morphology was not signifi cantly altered at the 1-h 
time point as observed by a ∼15% reduction in the number of cells 
with wild-type structures ( Figure 8C and Supplemental Figure S5C). 
In addition, we did not detect noticeable alterations in ER exit site 
morphology when Sec13p-GFP was observed in  pik1–83 cells 
compared to wild type (unpublished data). Both  cis - and  trans- Golgi 
membrane markers, however, showed an increase in the number of 
smaller Golgi puncta accompanied by larger ring-like structures that 
presumably correspond to Berkeley bodies also observed in  arf1Δ , 
 gea1Δ ,  sec7–1 , and  pik1–101 mutants ( Gaynor  et al. , 1998 ;  Peyroche 
 et al. , 2001 ;  Bruinsma  et al. , 2004 ; Karhinen and Makarow,  2004 ; 
 Demmel  et al. , 2008 ). Quantifi cation of Golgi morphologies demon-
strated acute defects at  trans- Golgi compartments with a ∼64% re-
duction the number of cells with wild-type  trans- Golgi structures 
and moderate defects at  cis -Golgi compartments with a ∼36% 
reduction in the number of cells with wild-type  cis -Golgi structures 
( Figure 8, D and E , and Supplemental Figure S5C). These observa-
tions indicate that Pik1p defi ciency does not cause a general loss 
of Golgi membranes and is consistent with a block in both export 
from  trans- Golgi compartments and transport into  cis -Golgi 
compartments. 
 DISCUSSION 
 The study of anterograde ER-to-Golgi traffi c has yielded a compre-
hensive list of proteins and mechanisms involved in vesicle budding, 
cargo sorting, and fusion of COPII vesicles with the Golgi complex. 
We know little, however, about the role that specifi c lipids play in 
these processes. To advance our understanding, we performed the 
fi rst screen for phosphoinositide requirements in anterograde ER-
to-Golgi transport in yeast using a number of lipid-binding domains, 
enzymes, and enzyme inhibitors in cell-free budding, tethering, and 
fusion assays. We classifi ed the effects of these compounds into 
distinct categories. The fi rst group comprised the PI(4,5)P 2 binding 
domains (ENTH and MED), which did not have a signifi cant effect on 
ER-to-Golgi transport. A second group comprised inhibitors that 
targeted both budding and fusion and included the PLC inhibitor 
U73122, a PI-specifi c PLC, and the PI(3)P binding domain (FYVE). A 
third group comprised inhibitors that specifi cally targeted fusion of 
COPII vesicles and included the PI(4)P and DAG binding domains 
(PH and C1b, respectively). 
 PI(4)P is the most abundant cellular phosphoinositide (Lemmon, 
 2008 ) and is prevalent at the Golgi complex with additional pools 
detected at the plasma and nuclear membranes ( D’Angelo  et al. , 
2008 ). In both yeast and mammalian cells, the Golgi pool of PI(4)P is 
required for Golgi secretory function ( D’Angelo  et al. , 2008 ), and 
was recently shown to be required for retention of  cis -, medial-, and 
 trans- Golgi glycosyltransferases in yeast ( Tu  et al. , 2008 ;  Wood 
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anism to control transport through the early secretory pathway. A 
refi ned cell-free fusion assay and facile genetic approaches should 
allow us to determine if specifi c ER-to-Golgi SNARE proteins or po-
tentially other fusion factors are recruited by PI(4)P to membrane 
fusion sites. 
 MATERIALS AND METHODS 
 Yeast strains and media 
 Yeast strains used in this study are listed in  Table 1 . Unless noted 
otherwise, cultures were grown at 26ºC (for temperature-sensitive 
mutant stains) or 30ºC in rich medium (YPD: 1% yeast extract, 2% 
peptone, 2% dextrose) or in minimal medium (YMD: 0.7% yeast ni-
trogen base without amino acids, 2% dextrose, and appropriate 
amino acid supplements). Standard yeast (Sherman,  1991 ) and clon-
ing protocols ( Ausubel  et al. , 1987 ) were used. Yeast cells were 
transformed by the lithium acetate method (Elble,  1992 ). 
 Plasmids  pRS426-BOS1 and  YEp511-BET1 ( LEU2 ) have been de-
scribed ( Dascher  et al. , 1991 ;  Duden  et al. , 1994 ). Plasmid  pRS423-
SEC22 was constructed by subcloning a ∼1.5-kb  BamH I- EcoR V frag-
ment of  YEp511-SEC22 ( Dascher  et al. , 1991 ) into  pRS423 
( Christianson  et al. , 1992 ). Plasmids  pRS424-SED5 and  pRS327-SLY1 
were generated by amplifying BY4742 genomic DNA including 
300–500 bp upstream and downstream sequences and cloning into 
 pRS424 ( Christianson  et al. , 1992 ) or  pRS327 ( Eriksson  et al. , 2004 ). 
Plasmids generated in this study were confi rmed by sequencing. 
FY834 was transformed with appropriate empty vectors or with the 
 BET1 ,  BOS1 ,  SEC22 ,  SED5 , and  SLY1 2µ vectors to generate 
CBY3062 and CBY3061, respectively. Overexpression was con-
fi rmed by immunoblot ( Figure 6 ). 
 Wild-type (SEY6210) and  pik1–83 (AAY104) strains were trans-
formed with  pJK59 [ CEN SEC63-GFP URA3 ] ( Prinz  et al. , 2000 ), or a 
chromosomal  GFPx3 tag was introduced into the  SEC21 and  SEC7 
loci as described ( Rossanese  et al. , 2001 ) to generate CBY2970, 
CBY2973, CBY2974, CBY2980, CBY2983, and CBY2984. 
 Reagents 
 Purifi ed lipid-binding domains GST-ENTH ( Rosenthal  et al. , 1999 ), 
C1b (C-terminal glutathione S-transferase [GST] cleaved) ( Johnson 
not display thermosensitive defects in cell-free transport assays 
(Supplemental Figure S6). By increasing the time of  pik1–83 inacti-
vation compared to published reports ( Audhya  et al. , 2000 ), we 
detected a strong block in ER-to-Golgi transport. It is interesting to 
note that mutations that mislocalize Sac1p to the Golgi also pro-
duce kinetic delays in ER-to-Golgi transport in addition to antero-
grade transport defects from the Golgi ( Schorr  et al. , 2001 ;  Konrad 
 et al. , 2002 ). Taken together, these data are consistent with an in 
vivo requirement for PI(4)P in fusion of COPII vesicles with the Golgi 
apparatus. 
 What is the molecular function of PI(4)P in fusion? We observed 
that overexpression of the fusion factors  BET1 ,  BOS1 ,  SEC22 ,  SED5 , 
and  SLY1 partially rescued PH WT -mediated inhibition of COPII vesi-
cle fusion with Golgi membranes. This result indicates that PI(4)P 
may act concomitantly with SNARE protein function. We hypothe-
size that  cis -Golgi localized PI(4)P interacts directly with SNARE pro-
teins and increases their local concentrations at specifi c fusion sites 
to promote COPII vesicle fusion with the Golgi. There is precedent 
for this type of association. SNARE proteins are known to associate 
with membranes through phosphoinositide-binding domains, as is 
the case for the soluble SNARE Vam7p, which is recruited to the 
vacuolar membrane by PI(3)P ( Cheever  et al. , 2001 ;  Fratti  et al. , 
2004 ). Alternatively, SNARE proteins often contain polybasic jux-
tamembrane regions, which directly interact with negatively charged 
lipids (i.e., phosphatidic acid and phosphoinositides), as is the case 
for yeast and mammalian exocytic SNARE proteins. Moreover, these 
SNARE–lipid interactions are required for secretion and viability ( Van 
Komen  et al. , 2005 ;  Vicogne  et al. , 2006 ;  James  et al. , 2008 ;  Lam 
 et al. , 2008 ; Mendonsa and Engebrecht,  2009 ; Murray and Tamm, 
 2009 ;  Williams  et al. , 2009 ). Similar interactions between Golgi-
localized PI(4)P and specifi c motifs in ER-Golgi SNARE proteins may 
be required to catalyze effi cient fusion of ER-derived vesicles with 
Golgi membranes. 
 In summary, this study establishes a new requirement for PI(4)P in 
SNARE-dependent fusion of COPII vesicles with Golgi membranes. 
Given the level of conservation in ER-to-Golgi transport machinery, 
PI(4)P function in COPII vesicle fusion with the Golgi complex is 
likely to be conserved and therefore constitutes an additional mech-
Strain Genotype Source
AAY104 SEY6210; pik1Δ::HIS3 [pRS314-pik1–83] Audhya et al., 2000
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Brachmann et al., 1998
CBY1584 BY4742; sec22Δ::KANR [pRS313-SEC22(D153C)] Flanagan and Barlowe, 2006
CBY1676 BY4742; bet1Δ::KANR [pRS315-BET1(I83C)] Flanagan and Barlowe, 2006
CBY2970 SEY6210; [pSEC63-GFP, URA3, CEN (pJK59)] This study
CBY2973 SEY6210; SEC21-GFPx3 This study
CBY2974 SEY6210; SEC7-GFPx3 This study
CBY2980 AAY104; [pSEC63-GFP, URA3, CEN (pJK59)] This study
CBY2983 AAY104; SEC21-GFPx3 This study
CBY2984 AAY104; SEC7-GFPx3 This study
CBY 3061 FY834; [pRS423-SEC22, HIS3] [pRS424-SED5, TRP1] [YEp511-BET1, LEU2] 
[pRS426-BOS1, URA3] [pRS327-SLY1, LYS2]
This study
CBY3062 FY834; [pRS423] [pRS424] [pRS425] [pRS426] [pRS327] This study
FY834 MATα his3Δ200 ura3–52 leu2Δ1 lys2Δ202 trp1Δ63 Winston et al., 1995
SEY6210 MATα leu2–3,112 ura3–52 his3-Δ200 trp1-Δ901 lys2–801 suc2-Δ9 Robinson et al., 1988
 TABLE 1:  Strains used in the study. 
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 Antibodies and immunoblotting 
 Antibodies against CPY ( Rothblatt  et al. , 1989 ); Grh1p ( Behnia  et al. , 
2007 ); Kar2p (Brodsky and Schekman,  1993 ); Och1p, Erv46p ( Otte  et 
al. , 2001 ); Sly1p (Flanagan and Barlowe,  2006 ); Sec22p (Liu and Bar-
lowe,  2002 ); Bet1p, Bos1p ( Sogaard  et al. , 1994 ); α1,6-mannose link-
ages, Sed5p ( Cao  et al. , 1998 ); Sec63p ( Feldheim  et al. , 1992 ); Uso1p, 
Bet3p, Cog2p/Sec35p ( Ballew  et al. , 2005 ); Erv25p (Belden and Bar-
lowe,  1996 ); Gdi1p ( Garrett  et al. , 1994 ); Sec13p ( Salama  et al. , 1993 ); 
Ypt1p ( Rexach  et al. , 1994 ); Sec17p, Sec18p (Haas and Wickner, 
 1996 ); and Sec61p ( Stirling  et al. , 1992 ) have been described. Poly-
clonal antibodies were raised against full-length untagged Bug1p as 
follows: Bug1p was cloned into an Impact-CN protein expression 
vector, purifi ed according to the manufacturer’s specifi cations (New 
England Biolabs), and used to immunize rabbits by standard proce-
dures (Covance, Denver, PA). For Western blots, anti-Bug1p serum 
was diluted 1:1,000. Monoclonal anti-5HIS was purchased from QIA-
GEN. Western blot analysis was performed with nitrocellulose mem-
branes by using the SuperSignal West Pico chemiluminescent sub-
strate (Pierce Chemical, Rockford, IL) and developed with a UVP 
Bioimaging System (Upland, CA). Densitometric analysis of immuno-
blots was performed using ImageJ (Rasband,  1997–2005 ). 
 In vitro vesicle budding, tethering, and transport assays 
 Yeast semi-intact cell membranes and ER microsomes were pre-
pared as described ( Baker  et al. , 1988 ; Wuestehube and Schekman, 
 1992 ). Prior to assembling in vitro reactions, semi-intact cell mem-
branes or microsomes were incubated with indicated inhibitors and/
or recombinant Sec18p for 20 min at 4ºC, or with Sac1 WT for 30 min 
at 12ºC as described in the text and fi gure legends. In vitro assays 
to measure overall transport, vesicle budding, vesicle tethering, 
two-stage fusion reactions, and SNARE cross-linking assays using 
[35S]gpαf were performed as described (Barlowe,  1997 ;  Cao  et al. , 
1998 ; Flanagan and Barlowe,  2006 ). 
 For vesicle purifi cation on Nycodenz gradients, microsomes 
containing [ 35 S]gpαf were treated with 50 µM Sac1 WT for 30 min at 
12ºC and then used to generate COPII vesicles ( Cao  et al. , 1998 ). 
ER-derived vesicles were purifi ed by fl otation on Nycodenz density 
gradients prepared in D 2 O to strip peripherally associated mem-
brane proteins, and then fl oated vesicles were chased into washed 
semi-intact cell membranes at 23ºC for 1 h (Barlowe,  1997 ). 
 Pulse-chase experiments 
 Wild type (SEY6210) and  pik1–83 (AAY104) strains were grown at 
26ºC in minimal medium to 0.4 OD 600 /ml (Beckman DU®-64 Spec-
trophotometer; Fullerton, CA), and then shifted to 37ºC for 25 min. 
These cultures were washed in 37ºC-warm pulse-chase medium lack-
ing cysteine, methionine, and sulfate, concentrated to 4 OD 600 /ml 
( Audhya  et al. , 2000 ) and further incubated at 37ºC. In total, cultures 
were shifted to 37ºC for 45 min prior to the pulse. Cultures were 
pulsed for 7 min by the addition of EasyTag EXPRESS 35 S Protein 
Labeling Mix (Perkin Elmer-Cetus, Waltham, MA) to a fi nal concen-
tration of ∼25 µCi/OD 600 . Cells were chased by the addition of 
cysteine, methionine, and (NH 4 ) 2 SO 4 at a fi nal concentration of 
2.5 mM. Sample collection, lysis, and immunoprecipitations were 
performed as described (Belden and Barlowe,  1996 ). 
 Microscopy 
 Samples at the indicated time points were concentrated to 
14 OD 600 /ml in the presence of 0.008% methylene blue to identify 
live versus dead cells ( Teparic  et al. , 2004 ), and 3 ml was applied to 
slides. Fluorescent and bright fi eld images were acquired using a 
microscope (model BX51; Olympus) equipped with a 100-W mercury 
 et al. , 2000 ), GST-FYVE 2 ( Gillooly  et al. , 2000 ), MED ( Wang  et al. , 
2001 ), HIS 6 -Sec18p ( Thorngren  et al. , 2004 ), and U73122 were the 
gifts of Bill Wickner (Dartmouth). 
 Plasmids expressing the PH domain of human Fapp1 (PI(4)P 
 a da p tor  p rotein- 1 ; residues 1–99) as a wild-type construct (PH WT ) 
( Dowler  et al. , 2000 ) or as the W15N, R18K mutant (PH N,K ) (Weixel 
 et al. , 2008) cloned as N-terminal fusions with maltose binding 
protein (MBP) were the gifts of Christopher Stroupe (Dartmouth). 
MBP fusion proteins were purifi ed according to New England 
Biolabs (Ipswich, MA) recommendations and dialyzed into buffer 
88 (20 mM HEPES-KOH pH 7.0, 250 mM sorbitol, 150 mM KOAc, 
5 mM MgOAc) without sorbitol. Plasmids expressing the 
soluble domain of Sac1p (residues 1–507) as a wild-type HIS 6 -Sac1 
construct (Sac1 WT ) or the catalytically inactive C392S mutant 
(Sac1 C392S ) were the gifts of Gregory Taylor (University of Nebraska 
Medical Center). His 6 fusion proteins were purifi ed according 
to QIAGEN (Valencia, CA) recommendations and dialyzed 
into buffer 88 without sorbitol containing 0.5 mM dithiothreitol 
(DTT). The activity of these Sac1 recombinant proteins was con-
fi rmed using synthetic liposomes as described ( Maehama  et al. , 
2000 ) and using semi-intact cell membranes (Supplemental 
Figure S1B). 
 PI-PLC was purchased from Invitrogen (Carlsbad, CA). Nycodenz, 
deuterium oxide (D 2 O), and methylene blue were purchased from 
Sigma Chemical (St. Louis, MO). Coomassie brilliant blue R-250 was 
purchased from Bio-Rad (Hercules, CA). All membrane transport in-
hibitors were diluted with buffer 88 to the appropriate concentration 
and screened for inhibition of in vitro transport at the indicated 
concentrations. 
 Lipids and liposome-binding assay 
 POPC, POPE, POPS, soy PI (Avanti Polar Lipids, Alabaster, AL), 
Rhodamine-labeled DHPE (Invitrogen, Carlsbad, CA) and diC16 
D-myo-PI(4)P (Echelon Biosciences, Salt Lake City, UT), were pur-
chased from the indicated sources. Liposomes were prepared as 
described ( Patki  et al. , 1997 ) with minor modifi cations. Lipids were 
mixed in glass tubes at the following molar ratios of 50% POPC, 
29.75% POPE, 0.25% Rhodamine labeled DHPE, 10% POPS, and 
10% soy PI or diC16 D-myo-PI(4)P, then dried to a thin fi lm under 
a stream of nitrogen gas and resuspended to a fi nal concentra-
tion of 2 mg total lipid / ml Sac1 phosphatase buffer ( Maehama 
 et al. , 2000 ): 100 mM NaOAc, 50 mM Bis-Tris, 50 mM Tris-HCl, 
pH 6.0, 2 mM DTT. Resuspended lipids were sonicated for 5 min 
at 30ºC, separated into 50-µl aliquots, fl ash-frozen, and stored 
at –70ºC. 
 Liposome-binding assays were as described ( Loyet  et al. , 1998 ) 
with minor modifi cations. Sac1 WT and Sac1 C392S proteins were pre-
cleared by centrifugation at 270,000 ×  g for 10 min. Binding reac-
tions (70 µl) containing 3 µM precleared Sac1 WT or Sac1 C392S protein 
in Sac1 phosphatase buffer with or without 50 µl of PI or PI(4)P lipo-
somes were incubated for 30 min at 30ºC. Bovine serum albumin 
(BSA) was added to 1 mg/ml to minimize nonspecifi c binding. Lipo-
somes were recovered by sedimentation at 270,000 ×  g for 10 min, 
and an aliquot of the supernatant was collected. Pellets were washed 
with excess Sac1 phosphatase buffer containing BSA at 1 mg/ml 
and resuspended to the initial volume with wash buffer. Equivalent 
volumes were resolved on 7.5% SDS–PAGE gels and stained with 
0.05% Coomassie brilliant blue R-250. Densitometric analysis was 
performed using ImageJ (Rasband,  1997–2005 ). Fluorometric quan-
tifi cation of Rhodamine labeled DHPE (λex/λem 560 nm/580 nm) 
indicated that 87% ± 6.7% (SD) of the starting liposomes were 
recovered in pellet fractions. 
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arc lamp, Plan Apochromat 60× objective (1.4 NA) and a Sensicam 
QE CCD camera (Cooke Inc., Romulus, MI). The camera and micro-
scope were controlled by the IP Lab system (Scanalytics, Sunnyvale, 
CA). All images were processed in Openlab software (Improvision, 
Lexington, MA). 
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